Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
sábado, noviembre 21
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Biomerica Inc
BMRA
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$1.08
-0.02
-1.82%
al cierre: Nov 20, 4:00 PM EST
Get Report
Panorámica general
Noticias
Gráficos
Previsión de beneficios
Finanzas
Sentimiento
Propiedad
Comparar
Informe de acciones
Biomerica Financials
Biomerica (BMRA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Biomerica Q1 EPS $(0.37), Sales $1.265M Down From $1.380M YoY
Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.37) per share. The company reported $1.265 million in sales this quarter. This is a 8.33 percent decrease over sales of $1.380 million the same period last year.
Benzinga Newsdesk
PRO
Biomerica Q4 EPS $(0.38) Up From $(0.69) YoY, Sales $875.000K Up From $749.000K YoY
Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.38) per share. This is a 44.93 percent increase over losses of $(0.69) per share from the same period last year. The company reported $875.000 thousand in sales
Benzinga Newsdesk
PRO
Biomerica Q3 EPS $(0.44) Up From $(0.48) YoY, Sales $987.000K Down From $1.119M YoY
Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.44) per share. This is a 8.33 percent increase over losses of $(0.48) per share from the same period last year. The company reported $987.000 thousand in sales
Benzinga Newsdesk
PRO
Biomerica Q2 EPS $(0.45) Up From $(0.48) YoY, Sales $1.210M Down From $1.636M YoY
Benzinga Newsdesk
PRO
Biomerica Q1 Sales $1.380M Down From $1.807M YoY
Biomerica (NASDAQ:BMRA) reported $1.380 million in sales this quarter. This is a 23.63 percent decrease over sales of $1.807 million the same period last year.
Benzinga Newsdesk
PRO
Biomerica Q4 EPS $(0.69) Up From $(0.72) YoY, Sales $749.000K Down From $1.118M YoY
.
Benzinga Newsdesk